ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 288.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$394M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
251
New
Increased
Reduced
Closed

Top Buys

1 +$27.6M
2 +$20.5M
3 +$17.4M
4
ETNB
89bio
ETNB
+$12.6M
5
JANX icon
Janux Therapeutics
JANX
+$7.04M

Top Sells

1 +$105M
2 +$14.6M
3 +$7.97M
4
SAGE
Sage Therapeutics
SAGE
+$6.58M
5
VERV
Verve Therapeutics
VERV
+$5.27M

Sector Composition

1 Healthcare 87.7%
2 Financials 1.74%
3 Communication Services 0.1%
4 Consumer Discretionary 0.1%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IROHR
201
DELISTED
Iron Horse Acquisitions Corp Right
IROHR
-12,320
UCFI
202
CN Healthy Food Tech Group
UCFI
-25,000
STI icon
203
Solidion Technology
STI
$32.7M
0
XBI icon
204
State Street SPDR S&P Biotech ETF
XBI
$8.28B
0
VIR icon
205
Vir Biotechnology
VIR
$1.3B
-250,000
VERV
206
DELISTED
Verve Therapeutics
VERV
-469,018
TRVI icon
207
Trevi Therapeutics
TRVI
$1.61B
-30,000
THRD
208
DELISTED
Third Harmonic Bio
THRD
-622,873
SWTX
209
DELISTED
SpringWorks Therapeutics
SWTX
-24,082
STTK icon
210
Shattuck Labs
STTK
$253M
-102,948
STOK icon
211
Stoke Therapeutics
STOK
$2.1B
-27,285
SNDX icon
212
Syndax Pharmaceuticals
SNDX
$1.92B
-10,000
SHY icon
213
iShares 1-3 Year Treasury Bond ETF
SHY
$24.9B
-53,337
SAGE
214
DELISTED
Sage Therapeutics
SAGE
-721,599
RNXT icon
215
RenovoRx
RNXT
$32.3M
-19,889
RLMD icon
216
Relmada Therapeutics
RLMD
$355M
-130,000
PYPD icon
217
PolyPid
PYPD
$79M
-103,950
PLRX icon
218
Pliant Therapeutics
PLRX
$78M
-82,189
NXTC icon
219
NextCure
NXTC
$43.9M
-9,834
NTRA icon
220
Natera
NTRA
$27.9B
-2,500
NETD
221
DELISTED
Nabors Energy Transition Corp II
NETD
-39,900
MOVE icon
222
Movano
MOVE
$14.8M
-1,915
KYMR icon
223
Kymera Therapeutics
KYMR
$7.21B
-13,366
KVACW icon
224
Keen Vision Acquisition Corp Warrant
KVACW
-75,000
KVAC icon
225
Keen Vision Acquisition Corp
KVAC
$110M
-75,000